SCHEMBL6860968

SCHEMBL6860968

COc1ncccc1-c1ccc(/C=C2/NC(=N)NC2=O)o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 5/20 0.44
▸ GSK3B P49841 5/20 0.44
▸ PIK3CG P48736 5/20 0.42
▸ DUSP3 P51452 1/20 0.40
▸ BTK Q06187 1/20 0.39
▸ MAPT P10636 3/20 0.37
▸ RECQL P46063 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ PIK3CA P42336 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ IDH1 O75874 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6858213 0.81 GSK3B (0.39) GSK3AGSK3BPIK3CGDUSP3MAPT
SCHEMBL6859360 0.80 GSK3A (0.43) GSK3AGSK3BPIK3CGDUSP3MAPT
SCHEMBL1116161 0.77 HTR2A (0.42) GSK3AGSK3BPIK3CGBTKMAPT
SCHEMBL1116163 0.77 HTR2A (0.42) GSK3AGSK3BPIK3CGBTKMAPT
SCHEMBL1116275 0.76 KDM4E (0.51) PIK3CGBTKMAPTRECQLKDM4E
SCHEMBL1116258 0.70 CLK1 (0.38) GSK3AGSK3BPIK3CGBTKMAPT
SCHEMBL1116259 0.70 CLK1 (0.38) GSK3AGSK3BPIK3CGBTKMAPT
SCHEMBL6858664 0.65 GSK3A (0.74) GSK3AGSK3BDUSP3MAPTRECQL
SCHEMBL622537 0.62 PIK3CG (0.79) GSK3AGSK3BPIK3CGMAPTRECQL
SCHEMBL622538 0.62 PIK3CG (0.79) GSK3AGSK3BPIK3CGMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback